The novel coronavirus (severe acute respiratory syndrome; SARS-CoV-2) pandemic has
spread rapidly throughout the planet. It is believed to have originated in the Wuhan province …

This is a comment on" COVID-19, cytokines and immunosuppression: what can we learn
from severe acute respiratory syndrome?" Clin Exp Rheumatol. 2020 Mar-Apr; 38 (2): 337 …

As a rheumatology community, we looked on the new decade with excitement and ambition
yet now instead find ourselves amidst the most significant global public healthcare …

The COVID-19 pandemic has already caused over 400 000 infections and led to over 17
000 deaths worldwide, dramatically disrupted daily life, and is placing extreme demands on …

Current pandemic of coronavirus disease 2019 (COVID-19) is caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). Despite drastic containment measures …

Poor outcomes in COVID‐19 correlate with clinical and laboratory features of cytokine storm
syndrome. Broad screening for cytokine storm and early, targeted antiinflammatory therapy …

The global COVID-19 pandemic has the potential to severely affect those with rheumatic
diseases or who are taking immunosuppressive therapies. Information is lacking as to how …

The ongoing pandemic coronavirus disease 19 (COVID-19) caused by the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) is a matter of global concern …

Objective To provide guidance to rheumatology providers on the management of adult
rheumatic disease in the context of the coronavirus disease 2019 (COVID‐19) pandemic …

Objective To provide guidance to rheumatology providers on the management of adult
rheumatic disease in the context of the coronavirus disease 2019 (COVID‐19) pandemic …